BETA-ADRENORECEPTOR BLOCKADE AND INDUCED HYPOTENSION

被引：1
|
作者：
MACRAE, WR [1 ]
机构：
[1] CITY HOSP,EDINBURGH EH3 9YW,SCOTLAND
来源：
ANAESTHESIA | 1983年 / 38卷 / 10期
关键词：
D O I：
10.1111/j.1365-2044.1983.tb12051.x
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：1005 / 1005
页数：1
相关论文
共 50 条
  • [1] BETA-ADRENORECEPTOR BLOCKADE IN HYPERTENSION
    LORIMER, AR
    DUNN, FG
    JONES, JV
    LAWRIE, TDV
    AMERICAN JOURNAL OF MEDICINE, 1976, 60 (06) : 877 - 885
  • [2] BETA-ADRENORECEPTOR BLOCKADE IN THE TREATMENT OF HYPERTENSION
    SLAVIN, MJ
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 1981, 80 (10): : 684 - 689
  • [3] ONCE DAILY BETA-ADRENORECEPTOR BLOCKADE IN HYPERTENSION
    MANN, S
    CRAIG, MWM
    BALASUBRAMANIAN, V
    CASHMAN, P
    RAFTERY, EB
    CLINICAL SCIENCE, 1979, 57 (03) : P16 - P16
  • [4] Beta-adrenoreceptor blockade abolishes atomoxetine-induced risk taking
    Yang, Fan Nils
    Pan, Jing Samantha
    Li, Xinwang
    PHYSIOLOGY & BEHAVIOR, 2016, 153 : 125 - 132
  • [5] EFFECT OF BETA-ADRENORECEPTOR BLOCKADE ON EXERCISE TOLERANCE IN EMPHYSEMA
    BUTLAND, RJA
    PANG, JACK
    GEDDES, DM
    CLINICAL SCIENCE, 1980, 58 (02) : P7 - P7
  • [6] Cardioselective beta-adrenoreceptor blockade with betaxolol in cardiovascular therapy
    Duplyakov, D. V.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2009, 8 (04): : 103 - 112
  • [7] BETA-ADRENORECEPTOR BLOCKADE AND PITUITARY-HORMONE LEVELS
    LEWIS, MJ
    GROOM, GV
    BARBER, R
    DART, A
    HENDERSON, AH
    CLINICAL SCIENCE, 1980, 58 (02) : P22 - P22
  • [8] EFFECTS OF BETA-ADRENORECEPTOR BLOCKADE AND NITROGLYCERIN ON MYOCARDIAL OXYGENATION
    WINBURY, MM
    WEISS, HR
    HOWE, BB
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1971, 16 (03) : 271 - +
  • [9] TREADMILL STRESS-TESTING UNDER BETA-ADRENORECEPTOR BLOCKADE
    LEHR, D
    NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (13) : 860 - 860
  • [10] INDORAMIN AND PRAZOSIN AS ADJUNCTS TO BETA-ADRENORECEPTOR BLOCKADE IN TREATMENT OF HYPERTENSION
    STOKES, GS
    FROST, GW
    GRAHAM, RM
    MACCARTHY, EP
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1979, 6 (06) : 669 - 669
12345